For example, CXCL12 expressed by niche cells in the BM attracts AML and CML cells, promotes survival and quiescence and resistance to therapy [66, 67]. This evidence concerns the gene CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive.